$TLRY

FALTISCHEK DENISE M purchased $12K of TLRY

FALTISCHEK DENISE M (Chief Strategy Officer) purchased 2,500 shares of Tilray Brands, Inc. (TLRY) at $4.78 on 2026-08-03.

Original reporting
SEC EDGAR · FALTISCHEK DENISE M
Published Aug 4, 2026, 2:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 3:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TLRY
Bullish
medium confidence
Mentioned
$TLRY
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TLRYBullishLow
01

Why it matters

A new insider open-market purchase was reported, which can slightly influence sentiment but does not change fundamentals on its own.

02

Market read

Traders may note the insider buy, but the disclosed value is small and there is no accompanying corporate catalyst.

03

What to watch

No 10b5-1 plan is cited, but the filing does not explain motivation, timing constraints, or whether the buy is part of a broader pattern.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed today, after-hours/late session visibility

Background

This is an SEC Form 4 insider transaction disclosure for Tilray Brands, Inc.

Company-level read

Ticker impact

$TLRYBullishMedium confidence
Context

Tilray Brands disclosed via Form 4 that Chief Strategy Officer Denise M. Faltischek bought 2,500 shares at $4.7800 on 2026-08-03.

Expected impact

Likely limited near-term impact; may add small incremental bullish sentiment rather than a catalyst.

Evidence & confidence

Form 4 is primary-source and new today, but the transaction value (~$12k) is small relative to typical market-moving thresholds and provides no guidance, deal, or operational change.

Market effects

No clear sector read-through; this is company-specific insider activity without broader regulatory or industry developments.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine liquidity or diversification rather than a strong fundamental signal, especially at small sizes.

Key entities

  • Tilray Brands, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Denise M. Faltischek

    Chief Strategy Officer who purchased 2,500 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TLRYLow

Should you sell your Tilray stock?

Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.

$TLRYMed

Tilray Brands revenue rises 20% in Q1 2027

Tilray Brands reported a 20% revenue increase to $257.1M in Q1 2027, driven by beverage sales. Gross profit rose 35% to $77.5M. Beverage revenue grew 82% to $101.5M, while cannabis revenue declined. The company reported a net loss of $40M but reduced debt by $42M. Tilray reaffirmed its adjusted EBITDA guidance of $68M-$75M for the fiscal year.

$TLRYMedAI 8/10

Tilray (TLRY) Q1 2027 Earnings Call Transcript

Tilray (TLRY) reported Q1 2027 revenue of $257 million, up 23% YoY, with expanded gross margins. The company highlighted its global scale, leadership in cannabis, beverage, and wellness, and strategic acquisitions like BrewDog. Tilray emphasized its diversified business model, international growth, and cost reductions in key markets like Portugal and Germany.

$TLRYMedAI 8/10

Tilray Brands Inc (TLRY) (Q1 2027) Earnings Call Highlights: Record Revenue

Tilray Brands Inc (TLRY) reported a Q1 net loss of $40M, down from a $1.5M profit last year, due to higher marketing costs and fuel surcharges. Revenue was impacted by cannabis price compression, supply constraints, and inventory shifts. BrewDog turned profitable, and the company expects continued growth. Tilray also discussed partnerships, international expansion, and potential M&A opportunities.

$TLRYHigh

Tilray Brands swings to $40M loss as revenue rises

Tilray Brands reported a net loss of $40.0 million for Q2 2026, despite revenue growth to $257.1 million. Gross profit rose to $77.5 million, but operating loss was $24.1 million. Cannabis revenue declined, while beverage revenue increased. The company issued shares to repay debt and amended credit agreements to ease covenant testing.